LONG-TERM EFFICACY OF INCOBOTULINUMTOXINA IN THE MANAGEMENT OF SIALORRHEA IN PARKINSON'S DISEASE

被引：0
|
作者：
Ianieri, Giancarlo [1 ]
Marvulli, Riccardo [1 ]
Gallo, Giulia [1 ]
机构：
[1] Univ Bari Aldo Moro, Neurosci & Sense Organs, Dept Basic Sci, Operat Unit Phys Med Rehabil & Sport, G. Cesar 11 Pl, I-70125 Bari, Italy
来源：
TOXICON | 2018年 / 156卷
关键词：
Botulinum toxin A; Dysphagia; Parkinson's disease; Sialorrhea;
D O I：
10.1016/j.toxicon.2018.11.112
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
102
引用
收藏
页码：S45 / S46
页数：2
相关论文
共 50 条
  • [1] Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson's disease and other neurologic conditions
    Pagan, F.
    Jost, W.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Flatau-Baque, B.
    Csikos, J.
    Blitzer, A.
    MOVEMENT DISORDERS, 2018, 33 : S754 - S754
  • [2] Long-term Efficacy and Safety of IncobotulinumtoxinA Treatment for Sialorrhea
    Pagan, Fernando
    Jost, Wolfgang H.
    Oehlwein, Christian
    Slawek, Jaroslaw
    Bogucki, Andrzej
    Ochudlo, Stanislaw
    Banach, Marta
    Csikos, Janos
    Blitzer, Andrew
    NEUROLOGY, 2019, 92 (15)
  • [3] LONG-TERM EFFICACY AND SAFETY OF INCOBOTULINUMTOXINA TREATMENT FOR SIALORRHEA
    Pagan, Fernando
    Jost, Wolfgang H.
    Michel, Olaf
    Oehlwein, Christian
    Slawek, Jaroslaw
    Bogucki, Andrzej
    Ochudlo, Stanislaw
    Banach, Marta
    Flatau-Baque, Birgit
    Csikos, Janos
    Blitzer, Andrew
    TOXICON, 2018, 156 : S86 - S87
  • [4] To evaluate the latency of sublingual atropine and the long-term effect in the management of sialorrhea in Parkinson's disease
    Cotton, P
    Hopcutt, B
    Flynn, M
    MOVEMENT DISORDERS, 2002, 17 : S108 - S108
  • [5] LONG-TERM INCOBOTULINUMTOXINA TREATMENT FOR CHRONIC SIALORRHEA: EFFICACY AND SAFETY OVER 64 WEEKS
    Jost, W.
    Friedman, A.
    Michel, O.
    Oehlwein, C.
    Slawek, J.
    Bogucki, A.
    Ochudlo, S.
    Banach, M.
    Pagan, F.
    Flatau-Baque, B.
    Dorsch, U.
    Csikos, J.
    Blitzer, A.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 39 - 39
  • [6] Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks
    Jost, Wolfgang H.
    Friedman, Andrzej
    Michel, Olaf
    Oehlwein, Christian
    Slawek, Jaroslaw
    Bogucki, Andrzej
    Ochudlo, Stanislaw
    Banach, Marta
    Pagan, Fernando
    Flatau-Baque, Birgit
    Dorsch, Ulrike
    Csikos, Janos
    Blitzer, Andrew
    PARKINSONISM & RELATED DISORDERS, 2020, 70 : 23 - 30
  • [7] Long-term efficacy of rasagiline in Parkinson's disease
    Lew, M
    Hauser, R
    Hurtig, H
    Ondo, W
    Wojcieszek, J
    NEUROLOGY, 2005, 64 (06) : A396 - A396
  • [8] Long-term efficacy of rasagiline in Parkinson's disease
    Lew, M
    Hauser, R
    Hurtig, H
    Ondo, W
    Wojcieszek, J
    MOVEMENT DISORDERS, 2005, 20 : S75 - S75
  • [9] INCOBOTULINUMTOXINA TO TREAT SIALORRHEA IN PARKINSON'S DISEASE: A REAL-LIFE STUDY
    Bergmans, B.
    Schotte, V.
    Sys, N.
    Van Massenhove, E.
    Van Zandijcke, M.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E69 - E70
  • [10] IncobotulinumtoxinA to treat sialorrhea in Parkinson's disease: A real-life study
    Bergmans, B.
    Schotte, V.
    Sys, N.
    Van Massenhove, E.
    Van Zandijcke, M.
    MOVEMENT DISORDERS, 2020, 35 : S389 - S389
12345